Matrix Metalloproteinase Expression After Human Cardioembolic Stroke: Temporal Profile and Relation to Neurological Impairment

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Stroke

• Publication date

  2001-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.STR.32.8.1759PMID 11486102
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Role for Matrix Metalloproteinase 9 after Focal Cerebral Ischemia: Effects of Gene Knockout and Enzyme Inhibition with BB-94

  2000cited by this paper
• Metalloproteinase Inhibition Reduces Thrombolytic (Tissue Plasminogen Activator)–Induced Hemorrhage After Thromboembolic Stroke

  2000cited by this paper
• Early Appearance of Activated Matrix Metalloproteinase-9 after Focal Cerebral Ischemia in Mice: A Possible Role in Blood—Brain Barrier Dysfunction

  1999cited by this paper
• Matrix Metalloproteinases Increase Very Early during Experimental Focal Cerebral Ischemia

  1999cited by this paper
• Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion.

  1999cited by this paper
• Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion.

  1999cited by this paper
• Matrix Metalloproteinases*

  1999cited by this paper
• Multivariable analysis of predictive factors related to outcome at 6 months after intra-arterial thrombolysis for acute ischemic stroke.

  1999cited by this paper
• Progression in acute stroke: value of the initial NIH stroke scale score on patient stratification in future trials.

  1999cited by this paper
• Local intra-arterial thrombolysis in acute ischemic stroke.

  1998cited by this paper
• Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain.

  1998cited by this paper
• Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size.

  1998cited by this paper
• Matrix Metalloproteinases in Cerebrovascular Disease

  1998cited by this paper
• Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes.

  1998influential reference
• Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke

  1997cited by this paper
• Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia.

  1997cited by this paper
• Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons.

  1996cited by this paper
• Proteolytic Cascade Enzymes Increase in Focal Cerebral Ischemia in Rat

  1996cited by this paper
• Interrater Agreement of Computed Tomography Infarct Measurement

  1996cited by this paper
• The Rev Axis of HIV-1 and Its Associated Host Cofactors: A Viral Window onto the Workings of Eukaryotic Posttranscriptional RNA Processing.

  1996cited by this paper
• Spontaneous middle cerebral artery reperfusion in ischemic stroke. A follow-up study with transcranial Doppler.

  1995cited by this paper
• Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat).

  1994cited by this paper
• Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial

  1993cited by this paper
• Urgent Therapy for Stroke: Part II. Pilot Study of Tissue Plasminogen Activator Administered 91-180 Minutes From Onset

  1992cited by this paper
• Human neutrophil gelatinase: A marker for circulating blood neutrophils. Purification and quantitation by enzyme linked immunosorbent assay

  1992cited by this paper
• Urgent Therapy for Stroke: Part I. Pilot Study of Tissue Plasminogen Activator Administered Within 90 Minutes

  1992cited by this paper
• Anatomy and freehand examination techniques

  1992cited by this paper
• Metalloproteinases and their inhibitors in matrix remodeling.

  1990influential reference
• Collagenolytic metalloenzymes of the human neutrophil. Characteristics, regulation and potential function in vivo.

  1986cited by this paper

• Combined treatment with tPA and Chinese herbal medicine for ischemic stroke: is it valuable?

  2026cites this paper
• "Targeting Neuroinflammation in Ischemic Stroke: The Promise of Phytoconstituents".

  2026cites this paper
• Blood-based MMP-9 for the early differentiation of acute ischemic stroke: a systematic review and meta-analysis.

  2025cites this paper
• Matrix metalloproteinase-9 in hemorrhagic transformation after acute ischemic stroke (Review)

  2025cites this paper
• Association between severity of stroke and poststroke epilepsy among patients with ischemic stroke: Mediating role of infection and early seizure

  2025cites this paper
• Terapeutic hypothermia in neuroprotection has an impact on neuroplasticity in brain ischemia and trauma

  2025cites this paper
• Blood-based protein biomarkers during the acute ischemic stroke treatment window: a systematic review

  2024cites this paper
• Inhibition of matrix metalloproteinases to reduce blood brain barrier disruption and haemorrhagic transformation in ischaemic stroke: go broad or go narrow?

  2024cites this paper
• The Roles of Circular RNAs in Ischemic Stroke through Modulating Neuroinflammation.

  2024cites this paper
• A Combined Extract Derived from Black Sticky Rice and Dill Improves Clinical Symptoms and Ischemic Stroke Biomarkers in Transient Ischemic Attack and Ischemic Stroke Patients

  2024influential citation
• Differences in Acute Expression of Matrix Metalloproteinases-9, 3, and 2 Related to the Duration of Brain Ischemia and Tissue Plasminogen Activator Treatment in Experimental Stroke

  2024cites this paper
• Mechanisms of neutrophil extracellular trap in chronic inflammation of endothelium in atherosclerosis.

  2023cites this paper
• Soluble ST2 Predicts Poor Functional Outcome in Acute Ischemic Stroke Patients

  2023cites this paper
• Implications of MMP-12 in the pathophysiology of ischaemic stroke

  2023cites this paper
• Blood-Brain Barrier Permeability and Kinetics of Inflammatory Markers in Acute Stroke Patients Treated With Thrombectomy

  2023cites this paper
• An MMP-9 exclusive neutralizing antibody attenuates blood-brain barrier breakdown in mice with stroke and stroke patient-derived MMP-9 activity.

  2023cites this paper
• Prognostic value of the systemic inflammation response index in patients with acute ischemic stroke

  2022cites this paper
• High neutrophil counts before endovascular treatment for acute basilar artery occlusion predict worse outcomes

  2022cites this paper
• Therapeutic efficacy of matrix metalloproteinase-12 suppression on neurological recovery after ischemic stroke: Optimal treatment timing and duration

  2022cites this paper
• Predictive value of longitudinal changes of serum matrix metalloproteinase-9 and brain-derived neurotrophic factor in acute ischemic stroke

  2022cites this paper
• Chronic cerebral hypoperfusion alters the CypA-EMMPRIN-gelatinase pathway: Implications for vascular dementia

  2022cites this paper
• Prolonged increased neutrophil-to-lymphocyte ratio is associated with mortality after successful revascularization for treatment of acute ischemic stroke

  2022cites this paper
• Prognostic value of serum MMP-9 level in acute ischemic stroke patient

  2022cites this paper
• Extracellular matrix metalloproteinase inducer in brain ischemia and intracerebral hemorrhage

  2022cites this paper
• Pathophysiology of Ischemic Stroke: Noncoding RNA Role in Oxidative Stress

  2022cites this paper
• Blood Biomarkers in the Diagnosis of Acute Stroke

  2021cites this paper
• The effects of memantine on the serum concentrations of matrix metalloproteinases and neurologic function of patients with ischemic stroke.

  2021cites this paper
• Neurovascular Alterations in Vascular Dementia: Emphasis on Risk Factors

  2021cites this paper
• Future Application: Prognosis Determination

  2021cites this paper
• Cytokines, brain proteins, and growth factors in acute stroke patients: A pilot study

  2021cites this paper
• Acute Stroke Biomarkers: Are We There Yet?

  2021cites this paper
• Dynamic change of MMP-9 in diabetic stroke visualized by optical imaging and treated with CD28 superagonist.

  2021cites this paper
• Infarct Volumes of Patients with Acute Ischemic Stroke Receiving Direct Oral Anticoagulants due to Non-Valvular Atrial Fibrillation

  2021cites this paper
• Sex Differences in Hemostatic Factors in Patients With Ischemic Stroke and the Relation With Migraine—A Systematic Review

  2021cites this paper
• Plasma Resolvin D2 to Leukotriene B4 Ratio Is Reduced in Diabetic Patients with Ischemic Stroke and Related to Prognosis

  2021cites this paper
• Early neutrophil to lymphocyte ratio is a prognostic marker in acute ischemic stroke after successful revascularization.

  2021cites this paper
• Application of contrast-enhanced magnetic resonance imaging in the assessment of blood-cerebrospinal fluid barrier integrity.

  2021cites this paper
• Non-invasive Urinary Biomarkers in Moyamoya Disease

  2021cites this paper
• The blood brain barrier in cerebral ischemic injury – Disruption and repair

  2020cites this paper
• Stroke Revisited: Pathophysiology of Stroke: From Bench to Bedside

  2020cites this paper
• The Mystery of Chemotherapy Brain: Kynurenines, Tubulin and Biophoton Release

  2020cites this paper
• Establishing molecular signatures of stroke focusing on omic approaches: a narrative review

  2020cites this paper
• EMMPRIN/CD147 plays a detrimental role in clinical and experimental ischemic stroke

  2020cites this paper
• Analysis of the association of MPO and MMP-9 with stroke severity and outcome

  2020cites this paper
• miRNA dysregulation in ischaemic stroke: Focus on diagnosis, prognosis, therapeutic and protective biomarkers

  2020cites this paper
• Matrix metalloproteinase-9 as a messenger in the cross talk between obstructive sleep apnea and comorbid systemic hypertension, cardiac remodeling, and ischemic stroke: a literature review

  2020cites this paper
• Emerging Mechanism of Cell Death Caused by Stroke: A Role of Neurovascular Unit

  2020cites this paper
• Quantified ischemic core’s radiological hypodensity and risk of parenchymal hematoma in > 4.5 h-window stroke thrombectomy

  2020cites this paper
• Stroke Biomarkers

  2020cites this paper
• Involvement of Matrix Metalloproteinase 9 in Vertebral Arterial Dissection With Posterior Circulation Ischemic Stroke

  2020cites this paper
• Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke.

  2019cites this paper
• Therapeutic Hypothermia and Neuroprotection in Acute Neurological Disease.

  2019cites this paper
• Neuron-Specific Enolase and Matrix Metalloproteinase 9 Signal Perioperative Silent Brain Infarction During or After Transcatheter Aortic Valve Implantation.

  2019cites this paper
• Spleen Derived Immune Cells in Acute Ischemic Brain Injury: A Short Review

  2019cites this paper
• Tissue inhibitor metalloproteinase-1 and clinical outcomes after acute ischemic stroke

  2019cites this paper
• High serum levels of tissue inhibitor of matrix metalloproteinase-1 during the first week of a malignant middle cerebral artery infarction in non-surviving patients

  2019cites this paper
• Gastrodin pretreatment alleviates rat brain injury caused by cerebral ischemic-reperfusion.

  2019cites this paper
• Vascular-Related Biomarkers of Ischemic Stroke

  2019cites this paper
• A Novel Algorithm for Dynamic Student Profile Adaptation Based on Learning Styles

  2019cites this paper
• A Canine Model of Hemorrhagic Transformation Using Recombinant Tissue Plasminogen Activator Administration After Acute Ischemic Stroke

  2019cites this paper
• Matrix metalloproteinases and ADAMs in stroke

  2019cites this paper
• BIIB093 (IV glibenclamide): an investigational compound for the prevention and treatment of severe cerebral edema

  2019cites this paper
• Causes and Consequences of MicroRNA Dysregulation Following Cerebral Ischemia-Reperfusion Injury.

  2019cites this paper
• Blood Biomarkers for Stroke Differentiation

  2019cites this paper
• Plasma levels of matrix metalloproteinase-9: A possible marker for cold-induced stroke risk in hypertensive rats.

  2019cites this paper
• Neuroinflammation: friend and foe for ischemic stroke

  2019cites this paper
• Neuroprotective Role of the Ron Receptor Tyrosine Kinase Underlying Central Nervous System Inflammation in Health and Disease

  2018cites this paper
• Plasma GFAP, Co-peptin & MMP-9 concentrations among West African Stroke subjects compared with Stroke free controls

  2018cites this paper
• Association of matrix metalloproteinase-3 with lesion localization and size in acute ischemic stroke

  2018cites this paper
• The Alteration of Plasma Matrix Metalloproteinase-9 Level after the Addition of Bromelin 500 mg to Standard Therapy of Acute Ischemic Stroke and Its Correlation with Outcome

  2018cites this paper
• Inflammatory molecules might become both biomarkers and therapeutic targets for stroke management

  2018cites this paper
• Profile of intravenous glyburide for the prevention of cerebral edema following large hemispheric infarction: evidence to date

  2018cites this paper
• Neutrophil-Lymphocyte Ratio Predicts Functional and Safety Outcomes after Endovascular Treatment for Acute Ischemic Stroke

  2018cites this paper
• Comparison of the perioperative time courses of matrix metalloproteinase-9 (MMP-9) and its inhibitor (TIMP-1) during carotid artery stenting (CAS) and carotid endarterectomy (CEA)

  2018cites this paper
• Changes in the secretome of tri-dimensional spheroid-cultured human mesenchymal stem cells in vitro by interleukin-1 priming

  2018cites this paper
• Effects of Kudiezi Injection on Serum Inflammatory Biomarkers in Patients with Acute Cerebral Infarction

  2018cites this paper
• Serum Matrix Metalloproteinase‐9 and Cognitive Impairment After Acute Ischemic Stroke

  2018cites this paper
• Serum prolidase enzyme activity as a diagnostic marker for acute ischemic stroke

  2018cites this paper
• Profile of intravenous glyburide for the prevention of cerebral edema following large hemispheric infarction: evidence to date

  2018cites this paper
• Association between Increased Matrix Metalloproteinase-9 (MMP-9) Levels with Hyperglycaemia Incidence in Acute Ischemic Stroke Patients

  2018cites this paper
• Blood biomarkers in ischemic stroke: potential role and challenges in clinical practice and research

  2018cites this paper
• Association of Polymorphisms of the Matrix Metalloproteinase 9 Gene with Ischaemic Stroke in a Southern Chinese Population

  2018cites this paper
• Effects of Vitamin D3 on the NADPH Oxidase and Matrix Metalloproteinase 9 in an Animal Model of Global Cerebral Ischemia

  2018cites this paper
• Differential immunological profiles herald magnetic resonance imaging-defined perioperative cerebral infarction

  2018cites this paper
• Neutrophil-To-Lymphocyte Ratio Predicts 3-Month Outcome of Acute Ischemic Stroke

  2017cites this paper
• Heme Oxygenase 1 expression after traumatic brain injury and effect of pharmacological manipulation on functional recovery.

  2017cites this paper
• Anti-Inflammatory Targets for the Treatment of Reperfusion Injury in Stroke

  2017cites this paper
• 12 Hyperbaric Oxygen for Stroke

  2017cites this paper
• Plasma thrombin-cleaved osteopontin as a potential biomarker of acute atherothrombotic ischemic stroke

  2017cites this paper
• D-4F increases microRNA-124a and reduces neuroinflammation in diabetic stroke rats

  2017cites this paper
• Plasma Glial Fibrillary Acidic Protein, Copeptin, and Matrix Metalloproteinase-9 Concentrations among West African Stroke Subjects Compared with Stroke-Free Controls.

  2017cites this paper
• Enhancing visual cortical plasticity in mice by enriching their environment: a combined imaging and behavioural study

  2017cites this paper
• (-)-Phenserine inhibits neuronal apoptosis following ischemia/reperfusion injury.

  2017cites this paper
• Peripheral blood AKAP7 expression as an early marker for lymphocyte-mediated post-stroke blood brain barrier disruption

  2017cites this paper
• Prediction Of Adverse Outcomes After Rt-Pa Treatment In Ischemic Stroke Patients

  2017cites this paper
• Hypoxia Response Element-Regulated MMP-9 Promotes Neurological Recovery via Glial Scar Degradation and Angiogenesis in Delayed Stroke.

  2017cites this paper
• Pathogenic mechanisms following ischemic stroke

  2017cites this paper
• The Roles of Autophagy and Inflammatory Responses in Acute Ischemic Stroke

  2016cites this paper
• Blood biomarkers in the early stage of cerebral ischemia.

  2016cites this paper
• The Role of Matrix Metalloproteinase 9 and Osteopontin in Synaptogenesis and Reinnervation of the Olfactory Bulb Following Brain Injury

  2016cites this paper